R
Rhythm develops predictive PAP technology designed to prevent RERAs, hypopneas, and apneas in patients with UARS or mild sleep apnea. This system detects early airway changes to deliver minimal, adaptive pressure only when needed, avoiding the high-pressure settings of traditional CPAP. The result is improved sleep quality and comfort without the need for pressure titration.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company develops predictive Positive Airway Pressure (PAP) technology specifically for Upper Airway Resistance Syndrome (UARS) and mild sleep apnea patients. Their device detects early airway changes to preemptively prevent RERAs, hypopneas, and apneas before they disrupt sleep. The system delivers minimal, adaptive pressure, eliminating the need for traditional pressure titration for greater patient comfort.